Jump to main content
Jump to site search


Effect of a novel potential probiotic Lactobacillus paracasei Jlus66 isolated from fermented milk on Nonalcoholic fatty liver in rats

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the main cause of chronic liver disease worldwide. Previous evidence indicates that probiotics can be applied as therapeutic agent for NAFLD. In this study, the potential probiotic strain Lactobacillus paracasei Jlus66 was isolated from natural fermented milk using a culture-dependent method, and its probiotic potentials were tested by established in vitro tests. In addition, the protective effect of Lactobacillus paracasei Jlus66 against NAFLD was evaluated in rat models. Compared with the high-fat-diet (HFD) group, the rats administered with 4 × 1010 cfu Jlus66 had significantly lower body weight gain, serum triglyceride (TG), low-density lipoprotein (LDL) as well as aminotransferase (ALT). Histopathological analysis showed Jlus66 also reduced the level of hepatic triglycerides and steatosis. From above we conclude that L. paracase Jlus66 has great potential as probiotics to protect from NAFLD.

Back to tab navigation

Supplementary files

Publication details

The article was received on 26 Jul 2017, accepted on 05 Oct 2017 and first published on 12 Oct 2017


Article type: Paper
DOI: 10.1039/C7FO01108C
Citation: Food Funct., 2017, Accepted Manuscript
  •   Request permissions

    Effect of a novel potential probiotic Lactobacillus paracasei Jlus66 isolated from fermented milk on Nonalcoholic fatty liver in rats

    H. Ye, Q. Li, Z. Zhang, M. Sun, C. Zhao and T. Zhang , Food Funct., 2017, Accepted Manuscript , DOI: 10.1039/C7FO01108C

Search articles by author

Spotlight

Advertisements